Trump administration could chart a new path on psychedelics, cannabis Drug policy was largely a backburner issue in 2025.
Lev Facher is an Addiction Reporter at STAT News. He covers a range of topics related to health and wellness, with a particular focus on cannabis and psychedelics, mental health, and the intersection of pharmaceuticals and healthcare. Lev's work has been featured in The Boston Globe, STAT News, and RamaOnHealthcare.
















